Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 30, 2019 $ 4 $ 128,651 $ (126,903) $ 1,752
Balance (in shares) at Jun. 30, 2019 4,208      
Stock-based compensation   2,734 0 2,734
Fair value of warrants issued to consultants for services   76 0 76
Issuance of common stock for cash: Related parties at $14.50 per share $ 2 19,998 0 20,000
Issuance of common stock for cash: Related parties at $14.50 per share (in shares) 1,380      
Issuance of common stock for cash: Other investors at $14.50 per share   4,050 0 4,050
Issuance of common stock for cash: Other Investors at $14.50 per share (in shares) 279      
Advisory fees and other offering costs   (1,500) 0 (1,500)
Net loss   0 (16,786) (16,786)
Balance at Mar. 31, 2020 $ 6 154,009 (143,689) 10,326
Balance (in shares) at Mar. 31, 2020 5,867      
Balance at Jun. 30, 2019 $ 4 128,651 (126,903) 1,752
Balance (in shares) at Jun. 30, 2019 4,208      
Net loss       20,300
Balance at Jun. 30, 2020 $ 6 154,595 (147,236) 7,365
Balance (in shares) at Jun. 30, 2020 5,867      
Balance at Dec. 31, 2019 $ 6 153,331 (138,649) 14,688
Balance (in shares) at Dec. 31, 2019 5,867      
Stock-based compensation   675 0 675
Fair value of warrants issued to consultants for services   3 0 3
Net loss   0 (5,040) (5,040)
Balance at Mar. 31, 2020 $ 6 154,009 (143,689) 10,326
Balance (in shares) at Mar. 31, 2020 5,867      
Balance at Jun. 30, 2020 $ 6 154,595 (147,236) 7,365
Balance (in shares) at Jun. 30, 2020 5,867      
Stock-based compensation   2,305 0 2,305
Fair value of warrants issued to consultants for services   8 0 8
Issuance of Units for cash $ 2 40,998 0 41,000
Issuance of Units for cash (In shares) 2,485      
Advisory fees and other offering costs   (3,550) 0 (3,550)
Issuance of common stock for services   7 0 7
Reclassification of derivative liability for authorized share deficiency   (3,591) 0 (3,591)
Net loss   0 (14,412) (14,412)
Balance at Mar. 31, 2021 $ 8 190,772 (161,648) 29,132
Balance (in shares) at Mar. 31, 2021 8,352      
Balance at Dec. 31, 2020 $ 8 193,831 (157,953) 35,886
Balance (in shares) at Dec. 31, 2020 8,352      
Stock-based compensation   530 0 530
Fair value of warrants issued to consultants for services   2 0 2
Reclassification of derivative liability for authorized share deficiency   3,591 0 3,591
Net loss   0 (3,695) (3,695)
Balance at Mar. 31, 2021 $ 8 $ 190,772 $ (161,648) $ 29,132
Balance (in shares) at Mar. 31, 2021 8,352